Dicarboxylic aminoaciduria

Dicarboxylic aminoaciduria is a rare inherited metabolic disorder characterized by excessive urinary excretion of dicarboxylic amino acids, specifically glutamic acid (glutamate) and aspartic acid (aspartate). The condition results from a defect in the renal tubular reabsorption of these acidic amino acids, leading to their increased loss in the urine. The underlying cause is believed to involve a dysfunction in the shared transport system responsible for reabsorbing dicarboxylic amino acids in the proximal renal tubules of the kidneys. Remarkably, dicarboxylic aminoaciduria is generally considered a benign biochemical condition. Most affected individuals are asymptomatic and do not develop significant clinical problems, as the body can compensate for the renal loss of glutamic acid and aspartic acid through dietary intake and endogenous synthesis. The condition is typically discovered incidentally during metabolic screening or urine amino acid analysis performed for other reasons. Because these amino acids are non-essential and can be synthesized by the body, the excessive urinary losses do not usually lead to deficiency states or systemic disease. No specific treatment is required for dicarboxylic aminoaciduria in most cases, given its benign nature. Management, if any, is supportive and may involve periodic monitoring of amino acid levels. The condition primarily affects the renal system at a biochemical level but does not typically cause kidney damage or dysfunction. It is important to distinguish this condition from other aminoacidurias that may have more significant clinical consequences. Genetic counseling may be offered to affected families to explain the nature and expected benign course of the condition.

Common questions about Dicarboxylic aminoaciduria